Defendant Profile · Consumer Product
Vivimed Losartan Class Action Settlement 2026 — Claim June 2
Quick answer
Vivimed Losartan Class Action Settlement 2026 — Claim June 2 has a Corp-Watch grade of A+ based on 1 tracked class action settlements in the Consumer Product industry.
View Vivimed Losartan Class Action Settlement 2026 — Claim June 2 settlement hub →Browse New York settlements →
Corporate Responsibility Matrix
Independent trust score from class action track record
A+93/100
A+
A
B
C
D
F
Active suits
0
Total public payouts
$1.9M
Avg distribution velocity
Insufficient data
Class action score100% weight
93/100
Updated Not yet computed. Methodology. Editorial grade — not legal advice.
Tracked cases against this defendant
Related investigations
Defendant FAQ
Questions about Vivimed Losartan Class Action Settlement 2026 — Claim June 2
- Corp-Watch grades (A+ through F) reflect litigation volume, payout pools, distribution timelines, and public regulatory signals. Grades refresh automatically every six hours.